The OphanTalent Academy #Sciathon project by Lindau Alumna Crina Samarghitean wants to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world. Help them by taking this survey: https://t.co/N5e6uSlgK6
I am proud to be taking part in #Sciathon#LINO23 with @CSamarghitean and @MadeleineHeep
Our project aims to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world.
Do you design AI-based educational tools?
Do you work in orphan diseases?
Would you like to be a mentor?
Do you have links with orphan charities?
Fill out this survey https://t.co/ISbwKtoNN0
#sciathon#LINO23
My best one? Auditing the use of continuous ECG monitoring on AMU. We've done this audit 3-4 times. @AlexNowbar@CJBeattie1991
Only when we implemented IT-based reminders, with buy-in from the head of the site operations team, did things start to improve.
ORBITA-2 will provide placebo-controlled data on the efficacy of PCI on symptoms in patients off antianginal medications. An ordinal clinical outcome scale for angina was designed in partnership with patients to be a relevant and inclusive primary outcome. https://t.co/kjYmYtV6jT
Excited to say the SAMSON Trial's full data has now been published in @JACCJournals. There is lots of interesting data, such as the remarkably similar timecourses of symptom onset and offset when starting and stopping statins and placebo https://t.co/kY7oAMbvsV
Calling everyone in UK that cares about the NHS.
When a drug goes off patent, it becomes cheap, yeh?
No.
If there is only one manufacturer they can screw us over for millions.
Please sign Karim Meeran's petition to the government which will fix this.
https://t.co/phpQFZKMHS
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding @rallamee @ProfDFrancis @AlexNowbar https://t.co/Dcidlaoyy7
Our latest coronary physiology paper online now @EuroInterventio.
You must have heard or read before that "flow in the right coronary artery can be predominantly systolic". True, a myth or a case report bias? We investigated this formally in the large IDEAL study dataset. 1/n
Thank you to @HelenRoutledge2, Andy Epstein and the team at Worcestershire Acute Hospitals NHS Trust for randomising the 100th patient into ORBITA-2. Amazing work! @rajkumar_chris@AlexNowbar@MikeFoley89